Vivariant

Mississauga, August 27, 2019 – Vivariant Laboratories Inc. – (the “Company” or “Vivariant”) is pleased to announce it has received a license for Analytical Testing of cannabis from Health Canada. “Today, after a 14-month journey, we have become a Health Canada licensed cannabis testing laboratory.  I am proud to share this accomplishment with everyone and owe it all to the hard work and dedication of our team and the support of our investors.” President Thomas Fraleigh said on Tuesday. “When we applied for regulatory approval in June 2018, Health Canada committed to a processing time that should have ended in…

Toronto, Feb. 23, 2018 - Vivariant Laboratories Inc. – (the "Company" or "Vivariant") is pleased to announce today the closing of a $1.022 million round of private equity financing (the "Offering") via the sale of common shares. The net proceeds raised from the Offering are intended to be used for further development of the Company's facility, equipment, and general corporate purposes. "We thank our investors for joining us in the quality assurance segment of the Cannabis sector," President Thomas Fraleigh said upon close. "These funds will be used for our facility build-out and licensed dealer application. Congratulations to the whole…